Stocks and Investing
Stocks and Investing
Mon, June 5, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sat, June 3, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, June 2, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mike Matson Reiterated (ATRC) at Strong Buy and Held Target at $60 on, Jun 2nd, 2023
Mike Matson of Needham, Reiterated "AtriCure, Inc." (ATRC) at Strong Buy and Held Target at $60 on, Jun 2nd, 2023.
Mike has made no other calls on ATRC in the last 4 months.
There are 3 other peers that have a rating on ATRC. Out of the 3 peers that are also analyzing ATRC, 0 agree with Mike's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mike
- Marie Thibault of "BTIG" Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, February 22nd, 2023
- Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $48 on, Wednesday, February 22nd, 2023
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $74 on, Wednesday, February 22nd, 2023
Contributing Sources